American International Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $18.3M | Sell |
|
|||||
|
2023
Q4 | $17.6M | Sell |
|
|||||
|
2023
Q3 | $15.6M | Sell |
|
|||||
|
2023
Q2 | $14M | Sell |
|
|||||
|
2023
Q1 | $15.1M | Sell |
|
|||||
|
2022
Q4 | $17.9M | Sell |
|
|||||
|
2022
Q3 | $16.1M | Sell |
|
|||||
|
2022
Q2 | $15.4M | Sell |
|
|||||
|
2022
Q1 | $15.1M | Buy |
|
|||||
|
2021
Q4 | $13.7M | Sell |
|
|||||
|
2021
Q3 | $15.7M | Sell |
|
|||||
|
2021
Q2 | $16.4K | Sell |
|
|||||
|
2021
Q1 | $16.6K | Buy |
|
|||||
|
2020
Q4 | $221 | Sell |
|
|||||
|
2020
Q3 | $232K | Sell |
|
|||||
|
2020
Q2 | $307K | Buy |
|
|||||
|
2020
Q1 | $180K | Sell |
|
|||||
|
2019
Q4 | $228K | Sell |
|
|||||
|
2019
Q3 | $199K | Hold |
|
|||||
|
2019
Q2 | $187K | Buy |
|
|||||
|
2019
Q1 | $183K | Sell |
|
|||||
|
2018
Q4 | $154K | Hold |
|
|||||
|
2018
Q3 | $265K | Hold |
|
|||||
|
2018
Q2 | $212K | Buy |
|
|||||
|
2018
Q1 | $168K | Sell |
|
|||||
|
2017
Q4 | $161K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $97K | Buy |
|
|||||
|
2017
Q1 | $85K | Sell |
|
|||||
|
2016
Q4 | $79K | Hold |
|
|||||
|
2016
Q3 | $103K | Sell |
|
|||||
|
2016
Q2 | $96.3K | Sell |
|
|||||
|
2016
Q1 | $1.98M | Sell |
|
|||||
|
2015
Q4 | $2.9M | Sell |
|
|||||
|
2015
Q3 | $2.05M | Sell |
|
|||||
|
2015
Q2 | $3.24M | Buy |
|
|||||
|
2015
Q1 | $2.65M | Sell |
|
|||||
|
2014
Q4 | $2.01M | Sell |
|
|||||
|
2014
Q3 | $1.61M | Buy |
|
|||||
|
2014
Q2 | $1.42M | Buy |
|
|||||
|
2014
Q1 | $1.41M | Buy |
|
|||||
|
2013
Q4 | $414K | Sell |
|
|||||
|
2013
Q3 | $506K | Sell |
|
|||||
|
2013
Q2 | $611K | Buy |
|